ANTXR1 and breast cancer: On the other hand, expression amounts of BC were different from those of CRC (Figure 2a, upper panel), where POSTN (breast SE, bSE = 3.6) showed the highest expression in BC tumors (GMS272720) differently from CRC, followed by SPARC (bSE = 3.5), DKK3 (bSE = 4.1), MMP2 (bSE = 4.9), ACTA2 (bSE = 1.7), PDPN (bSE = 5.4), FAP (bSE = 4.3), PDGFRB (bSE = 4.6), LRRC15 (bSE = 3.4), ANTXR1  (bSE = 2.8), VIM (bSE = 2.7), SLC24A3 (bSE = 0.9), INHBA (bSE = 2.3), and CCL2 (bSE = 5.0).